SC directs Hadiya’s father to produce her before it on Nov 27

Bengaluru, Mar 5: Amulya Leona, the 19-year-old woman who captured a nation’s attention by shouting full-throated slogans, allegedly in support of Pakistan, at a rally in Bengaluru, has reportedly held her composure under grilling by the Special Investigating Team (SIT).

The woman was arrested after her speech to an audience of protesters against the Citizenship Amendment Act on February 19, and was slapped with sedition charges.

Sources in the police said Amulya Leona seemed to be absolutely normal during interrogation by senior cops, unlike most other persons in such circumstances.

Not once throughout the grilling nor in judicial custody did she break down.

Amulya is said to have defended herself on charges that she shouted pro-Pakistan slogans. She made it clear that by speaking out at the rally at Freedom House, she did not mean to support the enemy country and that she was not against India.

Lower-rung officers said Amulya Leona seemed to be considerably influenced by the late firebrand activist Gowri Lankesh, who was shot dead in 2017.

In fact, the policewomen to whose charge she was entrusted right after she was arrested are said to have heaved a sigh of relief when she handed over to custody of prison staff.

An urban legend going around in lower-rung police circles is that Amulya Leona attended the funeral of Gowri Lankesh and fainted near where the late activist was buried. “It’s impossible for a 19-year-old to show such grit. We have seen hardcore criminals breaking down in custody. Forget about breaking down, Amulya Leona is becoming stronger,” they explain.

Udupi, Jun 1: As many as 73 people have been tested positive for coronavirus in Udupi district today.

The district has registered a total of 260 positive cases so far. Majority of the positive cases in Udupi district have inter-state travel history to Maharashtra.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.